<DOC>
	<DOC>NCT00037518</DOC>
	<brief_summary>This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.</brief_summary>
	<brief_title>A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism, Primary</mesh_term>
	<mesh_term>Parathyroid Neoplasms</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Patients must have parathyroid carcinoma or severe primary hyperparathyroidism; * Abnormally elevated calcium levels above 12.5 mg/dL; * Not be pregnant or nursing; * Not have had any type of cancer other than parathyroid carcinoma within the last 5 years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Severe primary hyperparathyroidism</keyword>
	<keyword>Parathyroid carcinoma</keyword>
</DOC>